// App-Quantinova.ai

3517 : A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry

Researchers

Presenter

  • Burcu F. Darst

Principal Investigators

  • Sue A. Ingles

  • Benjamin A. Rybicki

  • Barbara Nemesure

  • Esther M. John

  • Jay H. Fowke

  • Victoria L. Stevens

  • Sonja I. Berndt

  • Chad D. Huff

  • Jong Y. Park

  • Wei Zheng

  • Elaine A. Ostrander

  • Shiv Srivastava

  • John Carpten

  • Thomas A. Sellers

  • Maureen Sanderson

  • Dana C. Crawford

  • Olivier Cussenot

  • Jennifer Cullen

  • Rick A. Kittles

  • Jianfeng Xu

  • Zsofia Kote-Jarai

  • Luc Multigner

  • Marie-Elise Parent

  • Florence Menegaux

  • Geraldine Cancel-Tassin

  • Adam S. Kibel

  • Eric A. Klein

  • Phyllis J. Goodman

  • Jennifer J. Hu

  • Graham Casey

  • Anselm J. Hennis

  • Ian M. Thompson

  • Robin Leach

  • James L. Mohler

  • Elizabeth T. Fontham

  • Gary J. Smith

  • Jack A. Taylor

  • Rosalind A. Eeles

  • Laurent Brureau

  • Stephen J. Chanock

  • Stephen Watya

  • Janet L. Stanford

  • Diptasri Mandal

  • William B. Isaacs

  • Kathleen A. Cooney

  • William J. Blot

  • David V. Conti

  • Christopher A. Haiman

Medical Centers

  • University of Southern California, Los Angeles, CA

  • University of North Carolina, Chapel Hill, NC

  • Henry Ford Hosp, Detroit, MI

  • Stony Brook University, Stony Brook, NY

  • Cancer Prevention Institute of California, Fremont, CA

  • Vanderbilt University Medical Center, Nashville, TN

  • American Cancer Society, Atlanta, GA

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Vanderbilt University School of Medicine, Nashville, TN

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

  • Uniformed Services University of the Health Sciences, Bethesda, MD

  • Meharry Medical College, Nashville, TN

  • Case Western Reserve University, Cleveland, OH

  • Sorbonne Universites, Paris, France

  • University of Arizona College of Medicine and University of Arizona Cancer Center, Tucson, AZ

  • NorthShore University HealthSystem, Evanston, IL

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • UMR Inserm 1085, Rennes, France

  • University of Quebec, Laval, Quebec, Canada

  • Université Paris-Saclay, Université Paris-Sud, CESP (Center for Research in Epidemiology and Population Health), Inserm, Team Cancer-Environment, Villejuif, France

  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA

  • Cleveland Clinic, Cleveland, OH

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • University of Miami Miller School of Medicine, Miami, FL

  • University of Virgina, Charlottesville, VA

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Louisiana State University Health Sciences Center New Orleans, New Orleans, LA

  • Roswell Park Cancer Institute, Buffalo, NY

  • National Institute of Environmental Health Sciences, Research Triangle Park, NC

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • University Hospital of Pointe-à-Pitre, Guadeloupe, France

  • Makerere University College of Health Sciences,, Kampala/UG,

  • Johns Hopkins Hospital and Medical Institution, Baltimore, MD

  • Duke University College of Medicine, Durham, NC

Locations

  • United States

  • France

  • United Kingdom

  • Canada

  • Uganda

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved